Journal Information
Vol. 27. Issue. S5.October 2007
Pages 1-67
Full text access
¿El tolvaptán, un antagonista de los receptores de la vasopresina V2, ¿es un tratamiento eficaz para la hiponatremia euvolémica e hipervolémica?
Is tolvaptan (a vasopressin V2 receptor antagonist) effective in the management of isovolumic and hypervolaemic hypernatremia?
Visits
10613
F. Ortiz
This item has received
Download PDF
Idiomas
Nefrología (English Edition)
Article options
Tools